Award
National Cancer Institute 5R01CA276268-04
Mechanisms of response and resistance to KRAS inhibition in pancreatic cancer
Recipient
Not specified
Award Amount
$561,772.00
Ceiling
$561,772.00
Awarded
January 26, 2026
Identifier
5R01CA276268-04
Research grant awarded by NIH/NCI to study mechanisms of response and resistance to KRAS inhibition in pancreatic cancer, with a funding amount of $561,772 for fiscal year 2026.
Description
This is a research grant opportunity from the NIH/NCI for studies on KRAS inhibitors in pancreatic cancer, with an award amount of approximately $561,772 for fiscal year 2026. The project involves multiple aims including genetic screening, organoid modeling, and tumor microenvironment analysis.